| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.32364 |
| P698 | PubMed publication ID | 31402456 |
| P50 | author | Marilie Gammon | Q104751082 |
| Alfred I. Neugut | Q107503728 | ||
| Regina M. Santella | Q113619023 | ||
| Mary Beth Terry | Q75067963 | ||
| Tengteng Wang | Q87998144 | ||
| Patrick T Bradshaw | Q90024734 | ||
| Lauren E McCullough | Q90165899 | ||
| Susan L Teitelbaum | Q93243028 | ||
| P2093 | author name string | Jia Chen | |
| Xinran Xu | |||
| Alexandra J White | |||
| Yoon Hee Cho | |||
| P2860 | cites work | A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment | Q24803679 |
| Analysis of repetitive element DNA methylation by MethyLight | Q24814952 | ||
| Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer | Q25257496 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies | Q26751511 | ||
| Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 | ||
| Aspirin and breast cancer prevention: the estrogen connection | Q28168745 | ||
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
| Maternal pesticide exposure from multiple sources and selected congenital anomalies | Q29615590 | ||
| Quantitative assessment of promoter hypermethylation during breast cancer development | Q30811494 | ||
| Gene promoter methylation is associated with increased mortality among women with breast cancer | Q33848807 | ||
| Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. | Q33928300 | ||
| Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors | Q33942280 | ||
| Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle. | Q33958348 | ||
| Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study | Q33994275 | ||
| A data-based approach to diet questionnaire design and testing | Q34189078 | ||
| The causes and prevention of cancer | Q34204331 | ||
| DNA methylation in breast cancer | Q34304102 | ||
| Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study | Q34381496 | ||
| The Effects of Sex Protein Receptors and Sex Steroid Hormone Gene Polymorphisms on Breast Cancer Risk | Q34557717 | ||
| DNA methylation and breast carcinogenesis. | Q34770599 | ||
| A primer and comparative review of major US mortality databases | Q34960177 | ||
| Global DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active Women | Q35631631 | ||
| Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity. | Q35633512 | ||
| Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis | Q35661228 | ||
| COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin | Q35797114 | ||
| Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study | Q35911030 | ||
| DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study | Q35987862 | ||
| Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention | Q36002131 | ||
| The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project | Q36060158 | ||
| COX-2 expression is upregulated by DNA hypomethylation after hematopoietic stem cell transplantation. | Q36339283 | ||
| Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer | Q36445547 | ||
| Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients | Q36622838 | ||
| DNA methylation modifies the association between obesity and survival after breast cancer diagnosis | Q36961072 | ||
| Epigenetics and lifestyle | Q37119743 | ||
| BRCA1 promoter methylation is associated with increased mortality among women with breast cancer | Q37219292 | ||
| Overadjustment bias and unnecessary adjustment in epidemiologic studies | Q37348081 | ||
| Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival | Q37688202 | ||
| Common breast cancer risk variants in the post-COGS era: a comprehensive review | Q37690575 | ||
| Epigenetics and the environment: emerging patterns and implications | Q37972995 | ||
| Molecular pathways: the role of NR4A orphan nuclear receptors in cancer. | Q38008291 | ||
| Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: the best and the worst | Q38023979 | ||
| The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer | Q38454025 | ||
| Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies | Q38575448 | ||
| Progesterone Receptor Signaling Mechanisms | Q38886936 | ||
| CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients | Q38968012 | ||
| Breast cancer statistics, 2015: Convergence of incidence rates between black and white women | Q40379855 | ||
| A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements | Q40587967 | ||
| Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer | Q46782579 | ||
| Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention. | Q51109209 | ||
| Genes, genetics, and epigenetics: a correspondence | Q74349596 | ||
| Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression | Q77916758 | ||
| Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study | Q83812255 | ||
| Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer | Q84011209 | ||
| Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies | Q86718469 | ||
| Pre-diagnostic aspirin use and mortality after breast cancer | Q87998148 | ||
| Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention | Q88221125 | ||
| Cancer statistics, 2019 | Q90941571 | ||
| P433 | issue | 21 | |
| P921 | main subject | aspirin | Q18216 |
| P304 | page(s) | 3836-3844 | |
| P577 | publication date | 2019-08-12 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study | |
| P478 | volume | 125 |
Search more.